225 related articles for article (PubMed ID: 26983629)
1. Interleukin-22 promotes lung cancer cell proliferation and migration via the IL-22R1/STAT3 and IL-22R1/AKT signaling pathways.
Bi Y; Cao J; Jin S; Lv L; Qi L; Liu F; Geng J; Yu Y
Mol Cell Biochem; 2016 Apr; 415(1-2):1-11. PubMed ID: 26983629
[TBL] [Abstract][Full Text] [Related]
2. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
Zhang W; Chen Y; Wei H; Zheng C; Sun R; Zhang J; Tian Z
Clin Cancer Res; 2008 Oct; 14(20):6432-9. PubMed ID: 18927282
[TBL] [Abstract][Full Text] [Related]
3. The Akt1/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells.
Malanga D; De Marco C; Guerriero I; Colelli F; Rinaldo N; Scrima M; Mirante T; De Vitis C; Zoppoli P; Ceccarelli M; Riccardi M; Ravo M; Weisz A; Federico A; Franco R; Rocco G; Mancini R; Rizzuto A; Gulletta E; Ciliberto G; Viglietto G
Oncotarget; 2015 Dec; 6(40):42667-86. PubMed ID: 26486080
[TBL] [Abstract][Full Text] [Related]
4. Reciprocal activation between IL-6/STAT3 and NOX4/Akt signalings promotes proliferation and survival of non-small cell lung cancer cells.
Li J; Lan T; Zhang C; Zeng C; Hou J; Yang Z; Zhang M; Liu J; Liu B
Oncotarget; 2015 Jan; 6(2):1031-48. PubMed ID: 25504436
[TBL] [Abstract][Full Text] [Related]
5. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
[TBL] [Abstract][Full Text] [Related]
6. PKIB promotes cell proliferation and the invasion-metastasis cascade through the PI3K/Akt pathway in NSCLC cells.
Dou P; Zhang D; Cheng Z; Zhou G; Zhang L
Exp Biol Med (Maywood); 2016 Nov; 241(17):1911-1918. PubMed ID: 27325557
[TBL] [Abstract][Full Text] [Related]
7. Grb2-associated binder 2 silencing impairs growth and migration of H1975 cells via modulation of PI3K-Akt signaling.
Wang WJ; Mou K; Wu XF; Zhang JZ; Ren G; Qi JD; Xu YF; Yao X
Int J Clin Exp Pathol; 2015; 8(9):10575-84. PubMed ID: 26617767
[TBL] [Abstract][Full Text] [Related]
8. OGT regulated O-GlcNacylation promotes migration and invasion by activating IL-6/STAT3 signaling in NSCLC cells.
Ge X; Peng X; Li M; Ji F; Chen J; Zhang D
Pathol Res Pract; 2021 Sep; 225():153580. PubMed ID: 34391182
[TBL] [Abstract][Full Text] [Related]
9. shRNA‑mediated silencing of TARBP2 inhibits NCI‑H1299 non‑small cell lung cancer cell invasion and migration via the JNK/STAT3/AKT pathway.
Shi Y; Zuo D; Wang X; Han M; Wu Y
Mol Med Rep; 2016 Oct; 14(4):3725-30. PubMed ID: 27599909
[TBL] [Abstract][Full Text] [Related]
10. IL-22 promotes the migration and invasion of gastric cancer cells via IL-22R1/AKT/MMP-9 signaling.
Ji Y; Yang X; Li J; Lu Z; Li X; Yu J; Li N
Int J Clin Exp Pathol; 2014; 7(7):3694-703. PubMed ID: 25120745
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of ELF3 facilitates cell growth and metastasis through PI3K/Akt and ERK signaling pathways in non-small cell lung cancer.
Wang H; Yu Z; Huo S; Chen Z; Ou Z; Mai J; Ding S; Zhang J
Int J Biochem Cell Biol; 2018 Jan; 94():98-106. PubMed ID: 29208568
[TBL] [Abstract][Full Text] [Related]
12. IL22/IL-22R pathway induces cell survival in human glioblastoma cells.
Akil H; Abbaci A; Lalloué F; Bessette B; Costes LM; Domballe L; Charreau S; Guilloteau K; Karayan-Tapon L; Bernard FX; Morel F; Jauberteau MO; Lecron JC
PLoS One; 2015; 10(3):e0119872. PubMed ID: 25793261
[TBL] [Abstract][Full Text] [Related]
13. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
[TBL] [Abstract][Full Text] [Related]
14. Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3-dependent invasion in resistant non-small cell lung cancer cells.
Azijli K; Yuvaraj S; Peppelenbosch MP; Würdinger T; Dekker H; Joore J; van Dijk E; Quax WJ; Peters GJ; de Jong S; Kruyt FA
J Cell Sci; 2012 Oct; 125(Pt 19):4651-61. PubMed ID: 22797920
[TBL] [Abstract][Full Text] [Related]
15. IL-17 promoted metastasis of non-small-cell lung cancer cells.
Li Q; Han Y; Fei G; Guo Z; Ren T; Liu Z
Immunol Lett; 2012 Dec; 148(2):144-50. PubMed ID: 23089548
[TBL] [Abstract][Full Text] [Related]
16. TPPP3 Promotes Cell Proliferation, Invasion and Tumor Metastasis via STAT3/ Twist1 Pathway in Non-Small-Cell Lung Carcinoma.
Li Y; Bai M; Xu Y; Zhao W; Liu N; Yu J
Cell Physiol Biochem; 2018; 50(5):2004-2016. PubMed ID: 30404076
[TBL] [Abstract][Full Text] [Related]
17. Activation of M3 muscarinic receptor by acetylcholine promotes non-small cell lung cancer cell proliferation and invasion via EGFR/PI3K/AKT pathway.
Xu R; Shang C; Zhao J; Han Y; Liu J; Chen K; Shi W
Tumour Biol; 2015 Jun; 36(6):4091-100. PubMed ID: 25964092
[TBL] [Abstract][Full Text] [Related]
18. Cyclophilin B promotes cell proliferation, migration, invasion and angiogenesis via regulating the STAT3 pathway in non-small cell lung cancer.
Teng MR; Huang JA; Zhu ZT; Li H; Shen JF; Chen Q
Pathol Res Pract; 2019 Jun; 215(6):152417. PubMed ID: 31043353
[TBL] [Abstract][Full Text] [Related]
19. Isoflurane Promotes Non-Small Cell Lung Cancer Malignancy by Activating the Akt-Mammalian Target of Rapamycin (mTOR) Signaling Pathway.
Zhang W; Shao X
Med Sci Monit; 2016 Nov; 22():4644-4650. PubMed ID: 27897153
[TBL] [Abstract][Full Text] [Related]
20. ZNF452 facilitates tumor proliferation and invasion via activating AKT-GSK3β signaling pathway and predicts poor prognosis of non-small cell lung cancer patients.
Zhang X; Zhou H; Zhang Y; Cai L; Jiang G; Li A; Miao Y; Li Q; Qiu X; Wang E
Oncotarget; 2017 Jun; 8(24):38863-38875. PubMed ID: 28418919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
